Immuron Files 6-K, Reports ASX Announcement

Ticker: IMRN · Form: 6-K · Filed: Feb 21, 2024 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateFeb 21, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-issuer, ASX-announcement

TL;DR

**Immuron just filed a routine 6-K, signaling an ASX announcement, so keep an eye on Australian news for details.**

AI Summary

Immuron Limited, a foreign private issuer, filed a Form 6-K on February 21, 2024, to report an announcement made to the Australian Securities Exchange (ASX). The filing indicates that Immuron Limited operates from Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia, and its Commission File Number is 001-38104. The company files annual reports under Form 20-F.

Why It Matters

This filing provides transparency on Immuron's ongoing compliance with SEC regulations and its communication with the Australian Securities Exchange, which can impact investor perception and regulatory standing.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (6-K) indicating an announcement was made, not disclosing any specific financial or operational risks within the document itself.

Key Players & Entities

FAQ

What type of report did Immuron Limited file?

Immuron Limited filed a Form 6-K, which is a 'Report of Foreign Private Issuer' pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

What is Immuron Limited's Commission File Number?

Immuron Limited's Commission File Number is 001-38104.

Where is Immuron Limited's principal executive office located?

Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

Does Immuron Limited file annual reports under Form 20-F or Form 40-F?

Immuron Limited indicates by check mark that it files annual reports under cover of Form 20-F.

What was the purpose of this 6-K filing?

The purpose of this 6-K filing was to furnish information to the SEC regarding an announcement Immuron Limited published to the Australian Securities Exchange (ASX).

Filing Stats: 312 words · 1 min read · ~1 pages · Grade level 18.7 · Accepted 2024-02-21 08:00:38

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on February 21, 2024 titled: - “Presentation to Australian Biologics Festival 2024” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Presentation to Australian Biologics Festival 2024 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: February 21, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing